Clinical Trial Update: Venlafaxine as Adjunct Therapy in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating venlafaxine as an adjunct therapy for rheumatoid arthritis and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Effexor (venlafaxine)

Snippet

Sponsor: Ain Shams University | Conditions: Rheumatoid Arthritis | Phase 2 | Status: NOT_YET_RECRUITING